StocksFundsScreenerSectorsWatchlists
INFU

INFU - InfuSystem Holdings Inc Stock Price, Fair Value and News

8.56USD-0.24 (-2.73%)Delayed as of 28 Mar 2024, 02:45 pm ET

Market Summary

INFU
USD8.56-0.24
Delayedas of 28 Mar 2024, 02:45 pm
-2.73%

INFU Stock Price

View Fullscreen

INFU RSI Chart

INFU Valuation

Market Cap

186.4M

Price/Earnings (Trailing)

205.53

Price/Sales (Trailing)

1.52

EV/EBITDA

14.48

Price/Free Cashflow

18.45

INFU Price/Sales (Trailing)

INFU Profitability

EBT Margin

1.36%

Return on Equity

1.76%

Return on Assets

0.89%

Free Cashflow Yield

5.42%

INFU Fundamentals

INFU Revenue

Revenue (TTM)

122.8M

Rev. Growth (Yr)

16.97%

Rev. Growth (Qtr)

0.55%

INFU Earnings

Earnings (TTM)

907.0K

Earnings Growth (Yr)

55.53%

Earnings Growth (Qtr)

58.39%

Breaking Down INFU Revenue

52 Week Range

7.4511.44
(Low)(High)

Last 7 days

-3.2%

Last 30 days

-5.5%

Last 90 days

-16.1%

Trailing 12 Months

0.3%

How does INFU drawdown profile look like?

INFU Financial Health

Current Ratio

2.08

Debt/Equity

0.63

Debt/Cashflow

0.34

INFU Investor Care

Shares Dilution (1Y)

2.55%

Diluted EPS (TTM)

0.04

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023113.5M118.2M122.8M0
2022104.7M106.9M107.6M109.9M
2021100.3M99.1M100.6M102.4M
202084.5M90.8M94.4M97.4M
201968.8M72.2M77.0M81.1M
201869.9M69.4M68.5M67.1M
201769.9M68.7M69.0M71.1M
201672.3M73.5M72.4M70.5M
201565.8M66.4M68.1M70.5M
201464.8M66.5M67.4M66.5M
201359.2M59.8M61.3M62.3M
201256.0M57.0M56.6M58.8M
201149.3M51.9M53.7M54.6M
2010041.7M44.5M47.2M
200900039.0M

Tracking the Latest Insider Buys and Sells of InfuSystem Holdings Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 01, 2024
lachance carrie
acquired
-
-
50,000
president and coo
Mar 01, 2024
lachance carrie
sold (taxes)
-186,298
9.3
-20,032
president and coo
Feb 09, 2024
chupa addam
sold (taxes)
-13,190
9.6
-1,374
executive vp and cio
Feb 09, 2024
chupa addam
acquired
-
-
3,000
executive vp and cio
Sep 06, 2023
malhotra r. rimmy
sold
-126,072
10.0858
-12,500
-
Sep 05, 2023
malhotra r. rimmy
sold
-50,972
10.1945
-5,000
-
Sep 01, 2023
malhotra r. rimmy
sold
-128,036
10.2429
-12,500
-
Aug 31, 2023
malhotra r. rimmy
sold
-103,643
10.3643
-10,000
-
Aug 30, 2023
malhotra r. rimmy
sold
-50,871
10.1742
-5,000
-
Aug 29, 2023
malhotra r. rimmy
sold
-103,357
10.3357
-10,000
-

1–10 of 50

Which funds bought or sold INFU recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 11, 2024
VANGUARD GROUP INC
added
2.3
1,189,900
11,228,200
-%
Mar 05, 2024
GREENWOOD CAPITAL ASSOCIATES LLC
added
93.85
1,060,020
2,006,860
0.13%
Feb 28, 2024
AMERICAN INTERNATIONAL GROUP, INC.
reduced
-0.4
7,779
95,166
-%
Feb 15, 2024
Legal & General Group Plc
reduced
-9.13
-135
20,658
-%
Feb 15, 2024
BARCLAYS PLC
added
552
232,000
270,000
-%
Feb 15, 2024
Meros Investment Management, LP
added
0.42
831,436
9,318,310
4.42%
Feb 15, 2024
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.
reduced
-0.49
796,946
9,857,760
0.58%
Feb 14, 2024
WASATCH ADVISORS LP
added
3.41
1,030,720
8,923,260
0.05%
Feb 14, 2024
Royal Bank of Canada
added
9.85
79,000
467,000
-%
Feb 14, 2024
AMERIPRISE FINANCIAL INC
sold off
-100
-114,089
-
-%

1–10 of 47

Are Funds Buying or Selling INFU?

Are funds buying INFU calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own INFU
No. of Funds

Unveiling InfuSystem Holdings Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
awm investment company, inc.
9.4%
2e+06
SC 13G/A
Feb 13, 2024
vanguard group inc
5.03%
1,065,298
SC 13G
Feb 02, 2024
acuitas investments, llc
5.8%
1,225,151
SC 13G/A
Jan 29, 2024
blackrock inc.
5.6%
1,187,289
SC 13G
Nov 29, 2023
sansone advisors, llc
7.6%
1,612,194
SC 13D/A
Mar 28, 2023
shuda scott
2.1%
431,118
SC 13D/A
Feb 14, 2023
awm investment company, inc.
9.7%
2e+06
SC 13G/A
Jan 12, 2023
acuitas investments, llc
5.6%
1,154,308
SC 13G
Feb 05, 2021
minerva advisors llc
4.9%
-
SC 13G/A
Oct 05, 2020
meridian ohc partners, lp
2.5%
502,750
SC 13D/A

Recent SEC filings of InfuSystem Holdings Inc

View All Filings
Date Filed Form Type Document
Mar 14, 2024
NT 10-K
NT 10-K
Mar 14, 2024
8-K
Current Report
Mar 08, 2024
8-K
Current Report
Mar 08, 2024
8-K
Current Report
Mar 05, 2024
4
Insider Trading
Feb 14, 2024
SC 13G/A
Major Ownership Report
Feb 13, 2024
SC 13G
Major Ownership Report
Feb 13, 2024
4
Insider Trading
Feb 02, 2024
SC 13G/A
Major Ownership Report
Jan 29, 2024
SC 13G
Major Ownership Report

Peers (Alternatives to InfuSystem Holdings Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
196.9B
40.1B
-3.02% 19.11%
34.4
4.91
-8.12% -17.45%
71.2B
19.5B
2.28% 4.53%
56.69
3.65
4.02% -22.04%
24.6B
3.9B
3.45% 0.50%
55.33
6.38
3.42% 23.09%
21.7B
14.8B
1.75% 11.60%
8.16
1.46
2.12% 209.17%
MID-CAP
10.2B
2.7B
2.92% -30.26%
-16.04
3.83
-4.68% 82.43%
9.7B
12.3B
-3.34% -3.19%
23.21
0.78
-2.44% -22.68%
9.5B
3.5B
2.97% 25.27%
33.57
2.74
4.97% 18.89%
6.9B
4.0B
-2.47% -11.08%
-51.36
1.74
1.10% 85.84%
3.5B
366.4M
0.74% 28.92%
-577.22
9.59
33.86% 89.80%
2.5B
6.6B
-3.84% 3.03%
12.86
0.38
2.78% -0.87%
SMALL-CAP
1.5B
3.2B
47.53% -25.51%
-2.23
0.47
7.73% -1066.14%
379.3M
166.7M
5.16% -2.53%
-4.59
2.28
6.67% -456.34%
227.2M
329.5M
-13.41% -54.45%
-16.09
0.69
0.49% 64.22%
43.3M
52.3M
-46.12% -38.06%
-2.31
0.83
17.61% 19.28%
4.5M
3.7M
2.40% 338.46%
-0.37
1.19
5.77% 8.23%

InfuSystem Holdings Inc News

Latest updates
Defense World • 24 Mar 2024 • 09:07 am
InvestorsObserver • 15 Mar 2024 • 06:32 pm
Seeking Alpha • 14 Mar 2024 • 07:00 am
Seeking Alpha • 28 Feb 2024 • 08:00 am
CNN • 2 months ago

InfuSystem Holdings Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue0.5%31,90931,73530,37028,83027,27927,04226,76326,51926,56624,83424,46324,71125,12525,99921,55321,71021,48919,72318,19317,56316,677
Gross Profit-1.2%16,24616,44215,54016,08416,21914,90115,36715,31315,25815,05014,57614,99615,12215,97812,66312,94712,23811,35610,3419,9739,674
Operating Expenses-4.2%14,54915,19415,64715,05515,27614,69415,89213,71115,60914,35413,70313,96111,86911,47212,63011,63610,57510,38510,7619,8479,769
  S&GA Expenses-8.6%2,7282,9853,2242,9632,8943,0833,3192,8132,9082,6802,3762,3982,1962,4492,6182,4522,4022,4762,6022,1572,323
EBITDA Margin1.9%0.12*0.12*0.12*0.11*0.12*0.11*0.11*0.13*0.12*0.16*0.19*0.19*---------
Interest Expenses-9.2%563620484426385314277468270317322237283332403468488488460439370
Income Taxes121.0%431195-30244310427.00-462711-217-478-179-9,88138.0025.0029.0012.0029.0063.0059.00-56.0045.00
Earnings Before Taxes77.8%1,120630-626550547-137-8301,098-6653424827892,9784,165-3898171,164444-901-331-474
EBT Margin46.3%0.01*0.01*0.00*0.00*0.01*0.00*0.00*0.01*0.01*0.05*0.08*0.08*---------
Net Income58.4%689435-324107443-164-368387-44882066110,6702,9404,140-4188051,135381-960-275-519
Net Income Margin32.0%0.01*0.01*0.00*0.00*0.00*-0.01*0.00*0.01*0.12*0.15*0.18*0.18*---------
Free Cashflow82.1%4,1422,275-4684,1553,2215,2593,9003,3385,5185,9672,5137,383---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets-0.7%10210310299.0099.0099.0098.0098.0095.0096.0091.0097.0080.0084.0083.0079.0078.0072.0067.0064.0064.00
  Current Assets3.8%30.0029.0028.0025.0024.0023.0023.0022.0022.0022.0023.0030.0021.0023.0021.0019.0019.0017.0016.0018.0017.00
    Cash Equivalents20.1%0.000.000.000.000.000.000.000.000.000.003.0010.002.000.000.003.003.002.002.004.004.00
  Inventory6.7%6.006.006.005.005.005.004.004.004.004.003.003.004.004.004.003.003.003.003.002.002.00
  Net PPE-1.6%4.004.004.004.004.004.004.005.004.004.004.004.004.004.004.004.003.002.001.001.001.00
  Goodwill0%4.004.004.004.004.004.004.004.004.004.00-----------
Liabilities-4.2%51.0053.0054.0051.0051.0052.0052.0049.0048.0051.0048.0056.0051.0058.0061.0057.0056.0052.0048.0044.00-
  Current Liabilities10.9%14.0013.0014.0014.0013.0014.0014.0013.0014.0016.0012.0023.0020.0020.0024.0022.0022.0021.0018.0015.0015.00
  Long Term Debt-9.6%33.0036.0036.0033.0034.0034.0035.0033.0031.0032.0032.0029.0027.0033.0032.0030.0030.0027.0028.0029.0029.00
    LT Debt, Current-------0.000.000.001.001.009.008.008.007.008.007.006.005.005.005.00
    LT Debt, Non Current-9.6%33.0036.0036.0033.0034.0034.0035.0033.0031.0032.0032.0029.0027.0033.0032.0030.0030.0027.0028.0029.0029.00
Shareholder's Equity3.0%51.0050.0048.0048.0048.0046.0046.0048.0046.0045.0043.0041.0029.0026.0022.0022.0022.0020.0020.0020.0021.00
  Retained Earnings1.2%-58.70-59.39-59.82-59.34-59.35-58.79-58.28-53.90-43.00-42.55-43.37-44.03-54.70-57.64-61.78-61.37-62.17-63.31-63.69-62.73-62.45
  Additional Paid-In Capital0.6%10910810710610610410310289.0087.0086.0085.0084.0084.0084.0084.0084.0084.0083.0083.0083.00
Shares Outstanding0.6%21.0021.0021.0021.0021.0021.0021.0021.0020.0020.0020.0020.00---------
Float------172---370---151---52.00---
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations73.9%4,2642,452-1514,5663,4565,4174,0783,7115,7916,1632,6517,6128,4063,7055574,3415,2153,0501,2693,1813,364
  Share Based Compensation4.6%1,0631,0167205891,0661,1231,0471,4421,9551,3721,6351,388659357206217250----
Cashflow From Investing87.2%-300-2,339-3,051-3,052-3,502-2,781-2,143-5,627-4,424-8,462-2,802-3,212-458-4,456-4,036-5,462-7,621-3,789-2,771-2,807-1,154
Cashflow From Financing-1575.3%-3,937-2353,293-1,71298.00-2,730-1,7161,937-1,366-298-6,7363,309-6,4919281,1376113,861541-91662.00-689
  Buy Backs---1531001,0033504,006560-----------1049,027

INFU Income Statement

2023-09-30
Condensed Consolidated Statements of Operations and Comprehensive Income - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]    
Net revenues$ 31,909$ 27,279$ 94,014$ 81,084
Cost of revenues15,66311,06045,78634,597
Gross profit16,24616,21948,22846,487
Selling, general and administrative expenses:    
Provision for doubtful accounts(169)(90)(122)(84)
Amortization of intangibles2487047432,125
Selling and marketing2,7282,8948,9379,296
General and administrative11,74211,76835,83234,525
Total selling, general and administrative14,54915,27645,39045,862
Operating income1,6979432,838625
Other expense:    
Interest expense(563)(385)(1,667)(976)
Other expense(14)(11)(47)(69)
Income (loss) before income taxes1,1205471,124(420)
(Provision for) benefit from income taxes(431)(104)(324)331
Net income (loss)$ 689$ 443$ 800$ (89)
Net income (loss) per share:    
Basic (in dollars per share)$ 0.03$ 0.02$ 0.04$ 0
Diluted (in dollars per share)$ 0.03$ 0.02$ 0.04$ 0
Weighted average shares outstanding:    
Basic (in shares)21,095,40420,683,36620,968,71120,625,826
Diluted (in shares)21,719,40421,452,48321,615,70620,625,826
Comprehensive income:    
Net income (loss)$ 689$ 443$ 800$ (89)
Other comprehensive income:    
Unrealized gain on hedges2546052001,754
Provision for income tax on unrealized hedge gain(62)(146)(55)(423)
Net comprehensive income$ 881$ 902$ 945$ 1,242

INFU Balance Sheet

2023-09-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 161$ 165
Accounts receivable, net19,45516,871
Inventories6,0914,821
Other current assets4,0122,922
Total current assets29,71924,779
Medical equipment for sale or rental3,9752,790
Medical equipment in rental service, net of accumulated depreciation35,27839,450
Property & equipment, net of accumulated depreciation4,2334,385
Goodwill3,7103,710
Intangible assets, net7,6948,436
Operating lease right of use assets4,2914,168
Deferred income taxes9,2459,625
Derivative financial instruments2,1651,965
Other assets1,76180
Total assets102,07199,388
Current liabilities:  
Accounts payable7,6298,341
Current portion of long-term debt00
Other current liabilities6,6466,126
Total current liabilities14,27514,467
Long-term debt, net of current portion32,65533,157
Operating lease liabilities, net of current portion3,6723,761
Total liabilities50,60251,385
Stockholders’ equity:  
Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued00
Common stock, $0.0001 par value: authorized 200,000,000 shares; 21,183,526 shares issued and outstanding as of September 30, 2023 and 20,781,977 shares issued and outstanding as of December 31, 202222
Additional paid-in capital108,530105,856
Accumulated other comprehensive income1,6341,489
Retained deficit(58,697)(59,344)
Total stockholders’ equity51,46948,003
Total liabilities and stockholders’ equity$ 102,071$ 99,388
INFU
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
 CEO
 WEBSITEwww.infusystem.com
 EMPLOYEES420

InfuSystem Holdings Inc Frequently Asked Questions


What is the ticker symbol for InfuSystem Holdings Inc? What does INFU stand for in stocks?

INFU is the stock ticker symbol of InfuSystem Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of InfuSystem Holdings Inc (INFU)?

As of Wed Mar 27 2024, market cap of InfuSystem Holdings Inc is 186.42 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of INFU stock?

You can check INFU's fair value in chart for subscribers.

What is the fair value of INFU stock?

You can check INFU's fair value in chart for subscribers. The fair value of InfuSystem Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of InfuSystem Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for INFU so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is InfuSystem Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether INFU is over valued or under valued. Whether InfuSystem Holdings Inc is cheap or expensive depends on the assumptions which impact InfuSystem Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for INFU.

What is InfuSystem Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Mar 27 2024, INFU's PE ratio (Price to Earnings) is 205.53 and Price to Sales (PS) ratio is 1.52. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. INFU PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on InfuSystem Holdings Inc's stock?

In the past 10 years, InfuSystem Holdings Inc has provided 0.126 (multiply by 100 for percentage) rate of return.